Nonsurgical Treatment of Advanced Metastatic Cervical Disease in Cancer of the Larynx
- 9 June 2000
- journal article
- review article
- Published by S. Karger AG in ORL
- Vol. 62 (4) , 226-233
- https://doi.org/10.1159/000027750
Abstract
Historically, patients with advanced cervical adenopathy (N2 or N3) have between a 20 and 30% chance of surviving their disease at 5 years from treatment. Despite attempts at more aggressive surgical resection, including resection and reconstruction of the carotid artery, patients with advanced cervical adenopathy remain at the highest risk for the development of local recurrences and distant metastases. This chapter will review the current limitations of surgical resectability for advanced neck disease, discuss the evolution of combined chemoradiation therapy for these patients, and finally present promising recent technological advances in radiation oncology which will have significant impact on the treatment of these patients.Keywords
This publication has 3 references indexed in Scilit:
- A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary resultsHead & Neck, 1997
- Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancerHead & Neck, 1997
- Radiation oncologyJAMA, 1996